Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Metabolic modulation of tumours with engineered bacteria for immunotherapy

Abstract

The availability of L-arginine in tumours is a key determinant of an efficient anti-tumour T cell response 1-4. Consequently, increases of typically low L-arginine concentrations within the tumour may greatly potentiate the anti-tumour responses of immune checkpoint inhibitors, such as programmed death-ligand 1 (PD-L1)-blocking antibodies 5. However, currently no means are available to locally increase intratumoural L-arginine levels. Here we used a synthetic biology approach to develop an engineered probiotic Escherichia coli Nissle 1917 strain that colonizes tumours and continuously converts ammonia, a metabolic waste product that accumulates in tumours 6, to L-arginine. Colonization of tumours with these bacteria increased intratumoural L-arginine concentrations, increased the number of tumour-infiltrating T cells and had marked synergistic effects with PD-L1 blocking antibodies in the clearance of tumours. The anti-tumour effect of these bacteria was mediated by L-arginine and was dependent on T cells. These results show that engineered microbial therapies enable metabolic modulation of the tumour microenvironment leading to enhanced efficacy of immunotherapies.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41586-021-04003-2

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Research works printed but not linked: 1

  1. Malissen, M. et al. Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J. 14, 4641-4653 (1995). · DOI · Paper page

Cited by

See all 624

Metadata

Authors
Canale, F. P., Basso, C., Antonini, G., Perotti, M., Li, N., Sokolovska, A., Neumann, J., James, M. J., Geiger, S., Jin, W., Theurillat, J.-P., West, K. A., Leventhal, D. S., Lora, J. M., Sallusto, F., & Geiger, R.
Affiliations
  • Institute for Research in Biomedicine (CH)
  • Ente Ospedaliero Cantonale (CH)
  • ETH Zurich (CH)
  • Synlogic (United States) (US)
  • Institute of Oncology Research (CH)
Corresponding author
Geiger, Roger
Venue
Nature
Published
2021-10-06
Volume
598
Issue
7882
Pages
662-666
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W3174561819
Cited by
619
References
19
Citations by year
2026: 117 · 2025: 167 · 2024: 146 · 2023: 109 · 2022: 72 · 2021: 8
FWCI
44.40
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
engineered bacteria, Escherichia coli Nissle 1917, L-arginine, ammonia conversion, PD-L1 blockade, immune checkpoint inhibitors, tumor-infiltrating T cells, cancer immunotherapy, synthetic biology
MeSH terms
Microorganisms, Genetically-Modified, Animals, Arginine, Escherichia coli, Female, Immunotherapy, Mice, Inbred C57BL, Neoplasms, Experimental, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Mice, Knockout, Adoptive Transfer, Probiotics, Proteome, Cell Line, Tumor, Mice, Synthetic Biology, Tumor Microenvironment, Metabolic Engineering, B7-H1 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic modulation of tumours with engineered bacteria for immunotherapy. https://app.cochat.ai/papers/10.1038/s41586-021-04003-2
The paper
Canale, F. P., Basso, C., Antonini, G., Perotti, M., Li, N., Sokolovska, A., Neumann, J., James, M. J., Geiger, S., Jin, W., Theurillat, J.-P., West, K. A., Leventhal, D. S., Lora, J. M., Sallusto, F., & Geiger, R. (2021). Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature. https://doi.org/10.1038/s41586-021-04003-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.